The Online Investor

Slideshow Stock Splits

By The Online Investor Staff, updated Mon., Feb. 6, 2:10 AM

Slide #2. Liminal BioSciences Inc. (NASDAQ:LMNL) 1 for 10 Reverse Split

Announced: 1/26/2023
Stock Split: 1 for 10
Record Date: 1/31/2023
Pay Date: 2/1/2023
LMNL Optionable?: Yes

Liminal Biosciences is a clinical stage biopharmaceutical company focused on developing distinctive small molecule therapeutics for inflammatory, fibrotic and metabolic diseases using Co.'s drug discovery platform and data-driven approach. Co.'s research and development programs are focused on inflammatory, fibrotic and metabolic conditions in patients with respiratory, liver or renal disease. Co.'s pipeline is made up of three development programs. Co.'s main asset, fezagepras (also known as PBI-4050), a clinical-stage product candidate, as a potential nitrogen scavenger and its GPR84 antagonist and OXER1 antagonist programs, which are preclinical.
LMNL Detailed Information Page & Split History »

Company Name: 
Liminal Biosciences Inc

Open the LMNL Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes

Email EnvelopeFree LMNL Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Stock Splits Page |

Copyright © 1998 - 2023, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.